Abstract
Nonalcoholic fatty liver disease (NAFLD) is defined by excessive triglyceride deposition in liver, excluding alcoholic or drug factors. NAFLD has grown into a public health concern since it is a leading cause of chronic liver disease in wealthy areas due to obesity and its associated metabolic syndrome. NAFLD has two typical types: non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH). NASH significantly impacts the life quality and life expectancy of chronic liver disease. Moreover, NASH is fatal since it involves the onset of multiple chronic disease and may cause cirrhosis and liver failure. Potentially more worrying, NASH does not show any obvious symptoms in early stages, therefore, a more effective and precise NASH diagnostic technique is necessary. This review introduces the current research status of NASH and summarizes the obstacles and potential solution in this research.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
